In this presentation, Dr. Deming reviews the evaluation and management of hepatocellular carcinoma (HCC) in patients with hepatitis C, including current treatment strategies and multidisciplinary care considerations. She discusses evidence-based… […]
Keyword: hcc
Hepatocellular Carcinoma (HCC) in HCV: Screening and Surveillance | June 17, 2026
In this presentation, Dr. Deming reviews the screening and prevention guidelines for hepatocellular carcinoma (HCC), describes the recommendations for HCC screening and discusses the significance of on-going surveillance. […]
Read More… from Hepatocellular Carcinoma (HCC) in HCV: Screening and Surveillance | June 17, 2026
Hepatocellular Carcinoma (HCC) in HCV: Screening and Surveillance | June 17, 2026
In this presentation, Dr. Deming reviews the screening and prevention guidelines for hepatocellular carcinoma (HCC), describes the recommendations for HCC screening and discusses the significance of on-going surveillance. […]
Read More… from Hepatocellular Carcinoma (HCC) in HCV: Screening and Surveillance | June 17, 2026
Diabetes and HCV | December 11, 2025
In this presentation, Dr. Carol Greenlee, endocrinologist, discusses the relationship of diabetes, liver disease and HCV infection. Dr. Greenlee provides an overview of extra hepatic manifestations of HCV infection, HCV… […]
Diabetes and HCV | December 3, 2025
In this presentation, Dr. Carol Greenlee, endocrinologist, discusses the relationship of diabetes, liver disease and HCV infection. Dr. Greenlee provides an overview of extra hepatic manifestations of HCV infection, HCV… […]
Diabetes and HCV | January 24, 2024
In this presentation, Dr. Carol Greenlee, endocrinologist, discusses the relationship of diabetes, liver disease and HCV infection. Dr. Greenlee provides an overview of extra hepatic manifestations of HCV infection, HCV… […]
Screening for Hepatocellular Carcinoma | October 18, 2023
Incidence of hepatocellular carcinoma (HCC) is rising quickly in the United States, and AI/AN people are being affected greater than any other group. In this presentation, Dr. Jon Gerry, surgeon… […]
Read More… from Screening for Hepatocellular Carcinoma | October 18, 2023
Diabetes and HCV | April 5, 2023
In this presentation, Dr. Carol Greenlee, endocrinologist, discusses the relationship of diabetes, liver disease and HCV infection. Dr. Greenlee provides an overview of extra hepatic manifestations of HCV infection, HCV… […]
Residual Risk for HCC in Patients After HCV SVR | February 23, 2022
In this presentation, Dr. Raymond Chung, 2021 AASLD President and Director of Hepatology and the Liver Center at Massachusetts General Hospital, discusses the residual risk for hepatocellular carcinoma in patients after… […]
Read More… from Residual Risk for HCC in Patients After HCV SVR | February 23, 2022
Diabetes and HCV | December 9, 2021
In this video, Dr. Carol Greenlee, endocrinologist, discusses management of type 2 diabetes in patients with Hepatitis C Virus (HCV). Dr. Greenlee provides an overview of how HCV can potentially… […]
